Tech Company Financing Transactions
Paragon Genomics Funding Round
Cowin Venture Capital, Cloudstone Venture and Fosun International participated in a $8 million Series A venture round for Paragon Genomics. The round was announced on 9/14/2017.
Transaction Overview
Company Name
Announced On
9/14/2017
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Investors
Proceeds Purpose
With this funding, we will develop additional NGS assay products, particularly in the oncology and precision medicine space, and expand our United States commercial team.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3521 Investment Blvd. 1
Hayward, CA 94545
USA
Hayward, CA 94545
USA
Phone
Website
Email Address
Overview
At Paragon Genomics, we develop and commercialize rapid, easy-to-use, and ultra-high multiplex PCR-based target enrichment solutions for the Next-Generation Sequencing (NGS) markets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tao Chen
Chief Technical Officer
Zhitong Liu
Browse more venture capital transactions:
Prev: 9/14/2017: Green Dot Labs venture capital transaction
Next: 9/15/2017: Sixgill venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs